Olema Pharmaceuticals (OLMA) Accumulated Depreciation & Amortization (2020 - 2023)
Olema Pharmaceuticals (OLMA) reported Accumulated Depreciation & Amortization of $698000.0 for Q3 2023, up 44.21% year-over-year from $484000.0 in Q3 2022, and down 6.18% quarter-over-quarter from $744000.0 in Q2 2023.
Olema Pharmaceuticals (OLMA) Accumulated Depreciation & Amortization (2020 - 2023) Analysis & Trends
Olema Pharmaceuticals (OLMA) has 4 years of Accumulated Depreciation & Amortization data on file, last reported at $698000.0 in Q3 2023.
- Accumulated Depreciation & Amortization for Q3 2023 came in at $698000.0, up 44.21% year-over-year; the trailing twelve-month figure through Sep 2023 was $698000.0 (up 44.21% YoY), and the FY2022 annual result was $581000.0, up 159.38% from the prior year.
- Accumulated Depreciation & Amortization retreated to $698000.0 in Q3 2023 per OLMA's latest filing, from $744000.0 in the prior quarter.
- Over five years, Accumulated Depreciation & Amortization peaked at $744000.0 in Q2 2023 and troughed at $62000.0 in Q4 2020.
- A 4-year average of $374833.3 and a median of $350500.0 in 2022 frame the typical range for Accumulated Depreciation & Amortization.
- The sharpest annual moves came in 2022 and 2023: Accumulated Depreciation & Amortization jumped 340.0% in 2022, then surged 44.21% in 2023.
- A 4-year view of Accumulated Depreciation & Amortization shows it stood at $62000.0 in 2020, then surged by 261.29% to $224000.0 in 2021, then surged by 159.38% to $581000.0 in 2022, then advanced by 20.14% to $698000.0 in 2023.
- Business Quant data shows OLMA's Accumulated Depreciation & Amortization at $698000.0 in Q3 2023, $744000.0 in Q2 2023, and $681000.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Olema Pharmaceuticals | 1.08 Bn | 1.08 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 698,000.00 |
| Sep 30, 2023 | 698,000.00 |
| Jun 30, 2023 | 744,000.00 |
| Jun 30, 2023 | 744,000.00 |
| Mar 31, 2023 | 681,000.00 |
| Mar 31, 2023 | 681,000.00 |
| Dec 31, 2022 | 581,000.00 |
| Dec 31, 2022 | 581,000.00 |
| Sep 30, 2022 | 484,000.00 |
| Sep 30, 2022 | 484,000.00 |
| Jun 30, 2022 | 393,000.00 |
| Jun 30, 2022 | 393,000.00 |
| Mar 31, 2022 | 308,000.00 |
| Mar 31, 2022 | 308,000.00 |
| Dec 31, 2021 | 224,000.00 |
| Dec 31, 2021 | 224,000.00 |
| Sep 30, 2021 | 151,000.00 |
| Sep 30, 2021 | 151,000.00 |
| Jun 30, 2021 | 102,000.00 |
| Jun 30, 2021 | 102,000.00 |